Status:
COMPLETED
Comparative Analysis of Small and Large Plaque Psoriasis
Lead Sponsor:
Rockefeller University
Conditions:
Psoriasis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Psoriasis is a chronic, debilitating skin disorder with an estimated prevalence of 2%. Psoriatic skin lesions start with initial pinhead-sized macules and then coalesce into plaques of varying sizes. ...
Detailed Description
Psoriasis is a common chronic skin disorder with an estimated prevalence in populations of approximately 2%. Psoriatic skin lesions start with initial pinhead-sized macules and then coalesce into plaq...
Eligibility Criteria
Inclusion
- Self-identified as Korean (defined as being Korean and both parents are Korean)
- History of small and/or large plaque psoriasis, for at least six months
- At least 18 years of age
- No treatment with topical steroids or vitamin D analogues for at least 2 weeks prior to entering the study.
- No treatment with systemic therapies, including phototherapy, acitretin, cyclosporine, methotrexate and biologics 4 weeks prior to entering the study. Among biologics, Ustekinumab (Stelara®) requires a longer washout period of 12 weeks.
Exclusion
- Erythrodermic, or pustular psoriasis as the sole or predominant form of psoriasis.
- Photosensitizing illnesses such as lupus, polymorphous light eruption, or any disease known to be worsened by UV light exposure.
- History of malignant melanoma.
- Pregnancy.
- Immunocompromising diseases such as HIV infection.
- Inflammatory diseases such as but not limited to Crohn's Disease, Multiple Sclerosis, Rheumatoid Arthritis, Hashimoto's Disease.
- Any medical, psychological or social condition that, in the opinion of the Investigator, would jeopardize the health or well-being of the participant during any study procedures or the integrity of the data. Participants taking medications that induce photosensitivity may be included after careful review.
- Poorly controlled medical conditions of any kind.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT01920906
Start Date
January 1 2014
End Date
June 1 2015
Last Update
May 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Rockefeller University
New York, New York, United States, 10065